FDA Recalls Mislabelled Cetirizine HCL Tablets Distributed by Aidapak Services
Aidapak Services, LLC is recalling 5 mg Cetirizine HCL tablets that may have been mislabeled as 300 mg Lithium Carbonate ER tablets.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with potential for significant injury or hospitalization (such as mislabeling a common antihistamine as a mood stabilizer) are rated as Severe.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for 5 mg Cetirizine HCL tablets distributed by Aidapak Services, LLC. The recall is due to a labeling error where the tablets may have been mislabeled as 300 mg Lithium Carbonate ER tablets.
The affected product is identified by NDC 00378363501, pedigree AD32757_13, and expiration date 5/13/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The mislabeled product is identified by NDC 00054002125, pedigree AD39564_1, and expiration date 5/13/2014.
Consumers and healthcare providers should check their inventory for the specific pedigree and expiration date listed above. If the product is found, it should be returned to the distributor or a local pharmacy for disposal. Patients should consult their healthcare provider if they have taken the medication.
The recalled product
- Product
- CETIRIZINE HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378363501.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- CETIRIZINE HCL
- Tablet
- 5 mg has the following codes: Pedigree: AD32757_13
- EXP: 5/13/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02